"MindMed doses first subject in trial of tablets for generalised anxiety disorder" was originally created and published by ...

Anxiety and sleep are closely linked. Anxious people tend not to sleep well, and poor sleep may also predict future anxiety, ...

Like every other disorder, anxiety needs treatment when, through frequency or intensity, or both, worry interferes with functioning. Anxiety encourages the maladaptive response of avoidance of ...

Tips are provided here to help persons with eating disorders and their carers plan for holiday gatherings and manage eating ...

Mind Medicine Inc., a clinical-stage biopharmaceutical company developing novel product candidates to treat brain health ...

PTSD is a serious mental health condition marked by changes in mood, intrusive memories, avoidant behavior, and a heightened ...

It’s important to speak with your healthcare professional about treatment plans. Anxiety disorders are among the most common mental health conditions in the United States. It’s estimated that ...

Teenage eating disorders are a multifaceted issue that affects millions of adolescents worldwide. These disorders, including ...

The Batman actor Robert Pattinson once shared how he had body dysmorphia which lead to anxiety Read ahead the study which ...

Inc. (NASDAQ: MNMD), (the "Company" or "MindMed"), a clinical-stage biopharmaceutical company developing novel product ...

Avoidant personality disorder (AVPD) and social anxiety disorder (SAD) are both conditions that involve discomfort and withdrawal in social settings. They share several characteristics but are ...

MindMed has announced the dosing of the first patient in its phase 3 Voyage study of MM120 ODT, a pharmaceutically optimised form of lysergide D-tartrate (LSD) for treating Generalised Anxiety ...